Alan Cohen

Oct 22, 2024 | horrornews.net | Alan Cohen |Alan Freedland |Janel Spiegel

Directed by: Renny HarlinWritten by: Alan R. Cohen & Alan FreedlandBased on Characters Created by: Bryan BertinoProduced by: Courtney Solomon, p.g.a., Mark Canton, p.g.a., Christopher Milburn, Charlie Dombek, Gary Raskin, Alastair BurlinghamCast: Madelaine Petsch, Gabriel Basso, Ema HorvathSynopsis: The chilling next chapter of The Strangers franchise. DID YOU MISS US?

Oct 7, 2024 | nature.com | Alan Cohen |Martin Picard

AbstractAging involves seemingly paradoxical changes in energy metabolism. Molecular damage accumulation increases cellular energy expenditure, yet whole-body energy expenditure remains stable or decreases with age. We resolve this apparent contradiction by positioning the brain as the mediator and broker in the organismal energy economy.

Sep 15, 2024 | nature.com | Jesse R. Poganik |Daniel Belsky |Joe LaCroix |Alan Cohen |Steven R. Cummings |Luigi Ferrucci | +15 more

AbstractBiomarkers of aging (BOA) are quantitative parameters that predict biological age and ideally its changes in response to interventions. In recent years, many promising molecular and omic BOA have emerged with an enormous potential for translational geroscience and improving healthspan. However, clinical translation remains limited, in part due to the gap between preclinical research and the application of BOA in clinical research and other translational settings.

Mar 18, 2024 | aol.com | Selina Guevara |Erik Ortiz |Adrienne Broaddus |Alan Cohen

While the historic trials of the parents of Michigan school shooter Ethan Crumbley resulted in guilty verdicts, the parents of the four students killed at Oxford High School in 2021 said Monday their quest for accountability is far from over.

Feb 14, 2024 | nature.com | Chiara Herzog |Jesse R. Poganik |Kejun Ying |Daniel Belsky |Albert T. Higgins-Chen |Alan Cohen | +12 more

AbstractThe search for biomarkers that quantify biological aging (particularly ‘omic’-based biomarkers) has intensified in recent years. Such biomarkers could predict aging-related outcomes and could serve as surrogate endpoints for the evaluation of interventions promoting healthy aging and longevity. However, no consensus exists on how biomarkers of aging should be validated before their translation to the clinic.